×
About 16,566 results

ALLMedicine™ Ascites Center

Research & Reviews  7,929 results

Diagnosis, evaluation, and management of ascites and hepatorenal syndrome.
https://doi.org/10.1002/hep.31884
Hepatology (Baltimore, Md.); Biggins SW, Angeli P et. al.

May 4th, 2021 - This is a comprehensive guidance on the diagnosis, evaluation, and management of ascites and hepatorenal syndrome in patients with chronic liver disease from the American Association for the Study of Liver Diseases (AASLD). It replaces the prior A...

Is Serum-Ascites Vitamin D Gradient a Valid Marker for Diagnosing Spontaneous Bacterial...
https://doi.org/10.1093/labmed/lmab019
Laboratory Medicine; Abdel Hafez H, Madani H et. al.

May 3rd, 2021 - Spontaneous bacterial peritonitis (SBP) is considered the paradigmatic model of infection in patients with liver cirrhosis. Therefore, there is a need for an accurate and rapid method for SBP diagnosis. The aim of this study was to evaluate the va...

Optimal paracentesis volume for terminally ill cancer patients with ascites.
https://doi.org/10.1016/j.jpainsymman.2021.04.010
Journal of Pain and Symptom Management; Ito T, Yokomichi N et. al.

May 2nd, 2021 - Patients with malignant ascites often suffer from distressing symptoms, especially in their end-of-life stage. Although paracentesis is the most common treatment modality to alleviate such symptoms, the optimal volume of paracentesis is not known....

Thinking outside the box of ascites differential diagnosis.
https://doi.org/10.1097/MEG.0000000000001828
European Journal of Gastroenterology & Hepatology; Afecto EMP, Rodrigues MAR et. al.

Apr 28th, 2021 - Thinking outside the box of ascites differential diagnosis.|2021|Afecto EMP,Rodrigues MAR,Ponte AIL,Fernandes SS,|

No evidence of benefit of routine ascitic fluid analysis in refractory ascites undergoi...
https://doi.org/10.1097/MEG.0000000000002119
European Journal of Gastroenterology & Hepatology; Marques de Sá I, Bibi M et. al.

Apr 28th, 2021 - No evidence of benefit of routine ascitic fluid analysis in refractory ascites undergoing therapeutic paracentesis.|2021|Marques de Sá I,Bibi M,Moura M,Carvalhana S,Cortez-Pinto H,|

see more →

Guidelines  9 results

KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166105
Clinical and Molecular Hepatology;

Jul 11th, 2018 - KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications.|2018| ,|therapeutic use,therapeutic use,diagnosis,etiology,metabolism,therapy,therapeutic use,complications,diagnosis,therapy,complications,diagnosis,analysis,

Consensus Report by the Pediatric Acute Lung Injury and Sepsis Investigators and Pediat...
https://doi.org/10.1016/j.bbmt.2017.08.014
Biology of Blood and Marrow Transplantation : Journal of ... Mahadeo KM, McArthur J et. al.

Aug 21st, 2017 - Even though hepatic veno-occlusive disease (VOD) is a potentially fatal complication of hematopoietic cell transplantation (HCT), there is paucity of research on the management of associated multiorgan dysfunction. To help provide standardized car...

Diagnosis and management of acute kidney injury in patients with cirrhosis: revised con...
https://doi.org/10.1136/gutjnl-2014-308874
Gut Angeli P, Gines P et. al.

Jan 29th, 2015 - Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.|2015|Angeli P,Gines P,Wong F,Bernardi M,Boyer TD,|complications,diagnosis,therapy,complications,

Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012
https://www.aasld.org/sites/default/files/guideline_documents/141020_Guideline_Ascites_4UFb_2015.pdf
Bruce A. Runyon

Dec 31st, 2011 - Cirrhosis is the eighth leading cause of death in the United States, if expanded liver diagnosis codes are used. 5 Ascites is the most common of the 3 major complications of cirrhosis, the other complications are hepatic encephalopathy and variceal.

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial p...
https://doi.org/10.1016/j.jhep.2010.05.004
Journal of Hepatology;

Jul 16th, 2010 - EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.|2010| ,|therapeutic use,diagnosis,etiology,therapy,diagnosis,etiology,therapy,therapeutic use,diagnosis,etiol...

see more →

Drugs  85 results see all →

Clinicaltrials.gov  8,253 results

Diagnosis, evaluation, and management of ascites and hepatorenal syndrome.
https://doi.org/10.1002/hep.31884
Hepatology (Baltimore, Md.); Biggins SW, Angeli P et. al.

May 4th, 2021 - This is a comprehensive guidance on the diagnosis, evaluation, and management of ascites and hepatorenal syndrome in patients with chronic liver disease from the American Association for the Study of Liver Diseases (AASLD). It replaces the prior A...

Is Serum-Ascites Vitamin D Gradient a Valid Marker for Diagnosing Spontaneous Bacterial...
https://doi.org/10.1093/labmed/lmab019
Laboratory Medicine; Abdel Hafez H, Madani H et. al.

May 3rd, 2021 - Spontaneous bacterial peritonitis (SBP) is considered the paradigmatic model of infection in patients with liver cirrhosis. Therefore, there is a need for an accurate and rapid method for SBP diagnosis. The aim of this study was to evaluate the va...

Optimal paracentesis volume for terminally ill cancer patients with ascites.
https://doi.org/10.1016/j.jpainsymman.2021.04.010
Journal of Pain and Symptom Management; Ito T, Yokomichi N et. al.

May 2nd, 2021 - Patients with malignant ascites often suffer from distressing symptoms, especially in their end-of-life stage. Although paracentesis is the most common treatment modality to alleviate such symptoms, the optimal volume of paracentesis is not known....

Thinking outside the box of ascites differential diagnosis.
https://doi.org/10.1097/MEG.0000000000001828
European Journal of Gastroenterology & Hepatology; Afecto EMP, Rodrigues MAR et. al.

Apr 28th, 2021 - Thinking outside the box of ascites differential diagnosis.|2021|Afecto EMP,Rodrigues MAR,Ponte AIL,Fernandes SS,|

No evidence of benefit of routine ascitic fluid analysis in refractory ascites undergoi...
https://doi.org/10.1097/MEG.0000000000002119
European Journal of Gastroenterology & Hepatology; Marques de Sá I, Bibi M et. al.

Apr 28th, 2021 - No evidence of benefit of routine ascitic fluid analysis in refractory ascites undergoing therapeutic paracentesis.|2021|Marques de Sá I,Bibi M,Moura M,Carvalhana S,Cortez-Pinto H,|

see more →

News  287 results

Terlipressin Shows Benefit in Hepatorenal Syndrome but Risks Spark Concern
https://www.medscape.com/viewarticle/946833

Mar 3rd, 2021 - NEW YORK (Reuters Health) - Details of the phase-3 CONFIRM trial show the vasopressin analog terlipressin can reverse the effects of type 1 hepatorenal syndrome (HRS-1), although not without potentially serious side effects. The study, published i...

Hyponatremia Common in Patients With Indwelling Peritoneal Catheters
https://www.staging.medscape.com/viewarticle/940304

Nov 3rd, 2020 - NEW YORK (Reuters Health) - Hyponatremia is common in patients with indwelling peritoneal catheters for drainage of malignant ascites, according to a retrospective study. "We were surprised to find that over 80% of patients were hyponatremic after...

Hyponatremia Common in Patients With Indwelling Peritoneal Catheters
https://www.medscape.com/viewarticle/940304

Nov 3rd, 2020 - NEW YORK (Reuters Health) - Hyponatremia is common in patients with indwelling peritoneal catheters for drainage of malignant ascites, according to a retrospective study. "We were surprised to find that over 80% of patients were hyponatremic after...

Sarcopenia Does Not Worsen Survival After Shunting for Refractory Ascites
https://www.medscape.com/viewarticle/939918

Oct 28th, 2020 - NEW YORK (Reuters Health) - In patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites, sarcopenia is not associated with increased mortality, according to new research from the UK. "Until now...

Sarcopenia Does Not Worsen Survival After Shunting for Refractory Ascites
https://www.staging.medscape.com/viewarticle/939918

Oct 28th, 2020 - NEW YORK (Reuters Health) - In patients with cirrhosis undergoing transjugular intrahepatic portosystemic shunt (TIPS) for refractory ascites, sarcopenia is not associated with increased mortality, according to new research from the UK. "Until now...

see more →

Patient Education  3 results see all →